Dec 24 2024HEALTH
Understanding Rituximab's Impact on Systemic Sclerosis-ILD
Rituximab, a drug being tested for its potential in treating systemic sclerosis-associated interstitial lung disease (SSc-ILD), doesn't have the same effect on every patient. Scientists looked into why this is by examining data from the DESIRES trial and using machine learning. They found that the s
reading time less than a minute
